GENEVA, SWITZERLAND — Addressing global delegates at a high-level forum during the 79th World Health Assembly (WHA79) in Geneva, Union Minister of Health and Family Welfare Shri J.P. Nadda highlighted India’s clinical breakthroughs, announcing that the nation has deployed one of the world’s largest tuberculosis screening and early detection programmes as part of its aggressive campaign to eliminate the disease. Speaking at the specialized side event titled “Does Your Health System Struggle with Lung Health Screening?”—organized by the Stop TB Partnership and co-hosted by India, Japan, the Philippines, and Zambia—the Health Minister framed respiratory screening as a fundamental pillar of economic resilience and human dignity.
For medical practitioners, pulmonologists, and public health officials in India, this ministerial address outlines critical shifts in the National Tuberculosis Elimination Programme (NTEP). It underscores an aggressive pivot toward artificial intelligence, decentralized diagnostics, and community-driven clinical support networks.
Overcoming the Diagnostic Gap: The Advanced Technology Drive
A central focus of Minister Nadda’s address was the dramatic expansion of India’s diagnostic infrastructure to eliminate historical detection delays. Acknowledging that passive case-finding is clinically insufficient, the Minister detailed how the government has integrated advanced technology directly into rural and underserved sectors:
- Molecular Testing Platforms: Massive decentralization away from urban tertiary hubs to remote district laboratories.
- AI-Assisted Chest X-Rays: Algorithmic tools that immediately flag high-probability lesions, bypassing radiologist shortages.
- Handheld and Ultra-Portable Screening Devices: Enabling frontline workers to conduct point-of-care diagnostics right at the patient’s doorstep.
- The “Khushi” AI Chatbot: Launched within the newly minted TB Mukt Bharat App, this multilingual digital assistant operates on entry-level smartphones to provide immediate, real-time guidance on respiratory symptoms, nearby testing clinics, and government entitlements.
Hard Epidemic Data: India Outpacing Global Averages
For clinicians tracking epidemiological trends, the Minister presented verified metrics showing the tangible impact of India’s updated National Strategic Plan. Over the last decade, India’s intensive case-finding drives have vastly outpaced global benchmarks:
| Epidemiological Indicator | Progress Metric Achieved | Clinical Impact |
| TB Incidence Reduction | 21% Decline over the decade | Outpacing the global average reduction rate. |
| TB Mortality Reduction | 25% Decline over the decade | Reflecting early clinical stabilization and management. |
| Treatment Coverage Rate | 92% Total Coverage achieved | Ensuring near-universal access to first-line anti-TB regimens. |
| Undetected Case Load | Dropped from >10 Lakh to <1 Lakh annually | Minimizing the active pool of community transmission. |
Holistic Care: Moving Beyond Simple Pharmacotherapy
A critical takeaway for the medical fraternity is the government’s official stance that “diagnosis and prescription alone are clinically insufficient” to break the cycle of infection. Minister Nadda emphasized that successful outcomes require addressing social determinants.
Through the ongoing Ni-kshay Mitra and TB Mukt Bharat Abhiyaan, India has successfully mobilized corporate entities, civil institutions, and individual citizens to provide nutritional support baskets and financial assistance to patients. This comprehensive strategy actively mitigates the catastrophic out-of-pocket health expenditures that frequently lead to medication default among low-income populations.
The Global Call to Action
Concluding his speech at the World Health Organization (WHO) side event, Shri J.P. Nadda called on international policymakers to move from fragmented disease-control initiatives toward total health system transformation. He proposed a five-point global priority list:
- Mainstreaming lung health within all national Universal Health Coverage (UHC) frameworks.
- Expanding international access to affordable, non-patented digital diagnostic tools.
- Upgrading primary healthcare networks to serve as front-line respiratory defense lines.
- Incentivizing domestic manufacturing and localized technology transfers across the Global South.
- Securing sustainable, long-term public financing specifically dedicated to early screening workflows.
